Home » Topics » Regulatory » Patents

Patents
RSS

Hangzhou Innogate Pharma discloses IDO-1 and/or TDO inhibitors

Oct. 27, 2016

Changzhou Longthera Pharmaceuticals patents CDK/cyclin D1 inhibitors

Oct. 27, 2016

Harvard College presents antibacterial agents

Oct. 26, 2016

Gilead Sciences develops HIV integrase inhibitors

Oct. 26, 2016

Auspex Pharmaceuticals describes S1P1 receptor modulators

Oct. 26, 2016

Lewis and Clark Pharmaceuticals discloses A2B receptor antagonists

Oct. 26, 2016

Anacor Pharmaceuticals patents antiprotozoal agents

Oct. 26, 2016

U.S. scientists present RAS GTPases inhibitors

Oct. 25, 2016

Japanese researchers develop RISK-1 and/or PKB beta/Akt2 inhibitors

Oct. 25, 2016

Mutabilis describes beta-lactamase inhibitors

Oct. 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...